RxDoctor Payments Data

Fedor Panov, MD

Neurological Surgery · New York, NYNPI 1962661686

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $98,486 of the $121,639 with a category attached, or 81.0%. Neuropace, Inc. accounts for 64.4% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $28,197, 2.1 times the $13,120 reported in 2019.

$121,639in general payments, 2019–2025

Across 199 payments — averaging $611.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuropace, Inc.$78K
  • Zimmer Biomet$35K
  • Monteris Medical Corporation$2K
  • Abbott$1K
  • Boston Scientific$1K
  • Clearpoint Neuro, Inc.$983
  • plus $2K from 5 others
$60,237in research payments, 2019–2025

Across 9 payments — averaging $6692.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Monteris Medical Corporation$60K

What the payments were for

  • Consulting fees$98,48681%
  • Travel & lodging$11,93210%
  • Food & beverage$11,2229%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neuropace, Inc.102$78,311
Zimmer Biomet37$35,151
Monteris Medical Corporation13$2,489
Abbott15$1,344
Boston Scientific8$1,042
Clearpoint Neuro, Inc.10$983
Insightec,inc5$928
Microtransponder, Inc.3$682
Medtronic4$535
Kyowa Kirin, Inc.1$150
Cerapedics Inc.1$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$121,639 in reported general payments places this provider in the 85th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York

Medicare billing

Part B allowed, 2024
$65,640
Medicare patients
100
Services billed
214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →